Heterogeneous biological graph convolutional network for drug-target interaction prediction
PLOS One · 19.05.2026 · 21 (5) · e0348895
DOI: 10.1371/journal.pone.0348895 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 19.05.2026. Verfasst von Haoran Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of AI and Advanced Computing, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Drug Discovery, Computational Biology. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Higher Educational Institution of China, Xi’an Jiaotong-Liverpool University.
Abstract (Originalsprache)
Drug–target interaction prediction plays a critical role in drug discovery by identifying potential therapeutic targets and elucidating underlying molecular mechanisms. However, existing computational methods generally rely on limited biological modalities and inadequately capture heterogeneous associations. To overcome these limitations, we propose a Heterogeneous Biological Graph Convolutional Network (HBGCN) that employs a hierarchical graph propagation architecture to integrate multimodal biological information and learn homogeneous and heterogeneous representations for drug–target interaction prediction. By incorporating both direct and indirect meta-paths, HBGCN captures complex relational dependencies among diverse biological entities. Experimental results demonstrate that HBGCN achieves competitive performance on benchmark datasets. Case studies indicate that HBGCN effectively identifies therapeutic drug candidates and reveals proteins and gene expression patterns associated with drug regulation. The source code and dataset are available at https://github.com/Saxon0918/HBGCN .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of AI and Advanced Computing, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, China.
- School of Computer Science and Informatics, University of Liverpool, Liverpool, United Kingdom.
- School of Computer Engineering and Science, Shanghai University, Shanghai, Shanghai, China.
- Department of Clinical Laboratory, Huaibei People's Hospital, Huaibei, Anhui, China.
ORCID-Profile: Haoran Zhu, Jianjia Wang
Förderung
- Jiangsu Higher Educational Institution of China
- Xi’an Jiaotong-Liverpool University
Zitieren
APA
Zhu, H., Wang, J., Hua, Z., Wang, C., Zhang, Z., Yu, T., & Ge, L. (2026). Heterogeneous biological graph convolutional network for drug-target interaction prediction. PLOS One, 21(5), e0348895. https://doi.org/10.1371/journal.pone.0348895
Vancouver
Zhu H, Wang J, Hua Z, Wang C, Zhang Z, Yu T, et al. Heterogeneous biological graph convolutional network for drug-target interaction prediction. PLOS One. 2026;21(5):e0348895. doi:10.1371/journal.pone.0348895
BibTeX
@article{Zhu2026,
author = {Zhu, Haoran and Wang, Jianjia and Hua, Zhen and Wang, Chaoqun and Zhang, Zimu and Yu, Tong and Ge, Ling},
title = {Heterogeneous biological graph convolutional network for drug-target interaction prediction},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {5},
pages = {e0348895},
doi = {10.1371/journal.pone.0348895}
}
EUVIMED